A Prospective, Open Label Study of CERtican in KIdney Transplantation

NCT01594268 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Transplant

Interventions

DRUG: Everolimus

Sponsor

Novartis Pharmaceuticals